Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort

Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort

ObjectiveIn the light of the current COVID-19 epidemic and the availability of effective vaccines, this study aims to identify factors associated with non-response to anti-SARS-CoV-2 vaccines as immunological alteration associated with immune rheumatic diseases (IRD) and immunosuppressive medication...

Full description

Bibliographic Details
Main Authors: Daniele Mauro, Antonio Ciancio, Claudio Di Vico, Luana Passariello, Gelsomina Rozza, Maria Dora Pasquale, Ilenia Pantano, Carlo Cannistrà, Laura Bucci, Silvia Scriffignano, Flavia Riccio, Martina Patrone, Giuseppe Scalise, Piero Ruscitti, Maria Vittoria Montemurro, Antonio Giordano, Maria Teresa Vietri, Francesco Ciccia
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
vaccines
autoimmunity
rheumatic and muscoluskeletal disease
arthritis
connective tissue disease (CTD)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.901055/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.901055/full

Similar Items